Literature DB >> 19966055

Evidence for enhanced M3 muscarinic receptor function and sensitivity to atrial arrhythmia in the RGS2-deficient mouse.

Jari M Tuomi1, Peter Chidiac, Douglas L Jones.   

Abstract

Atrial fibrillation (AF) is the most common arrhythmia seen in general practice. Muscarinic ACh receptors (M2R, M3R) are involved in vagally induced AF. M2R and M3R activate the heterotrimeric G proteins, G(i) and G(q), respectively, by promoting GTP binding, and these in turn activate distinct K(+) channels. Signaling is terminated by GTP hydrolysis, a process accelerated by regulator of G protein signaling (RGS) proteins. RGS2 is selective for G(q) and thus may regulate atrial M3R signaling. We hypothesized that knockout of RGS2 (RGS2(-/-)) would render the atria more susceptible to electrically induced AF. One-month-old male RGS2(-/-) and C57BL/6 wild-type (WT) mice were instrumented for intracardiac electrophysiology. Atrial effective refractory periods (AERPs) were also determined in the absence and presence of carbachol, atropine, and/or the selective M3R antagonist darifenacin. Susceptibility to electrically induced AF used burst pacing and programmed electrical stimulation with one extrastimulus. Real-time RT-PCR measured atrial and ventricular content of RGS2, RGS4, M2R, M3R, and M4R mRNA. AERP was lower in RGS2(-/-) compared with WT mice in both the high right atrium (HRA) (30 +/- 1 vs. 34 +/- 1 ms, P < 0.05) and mid right atrium (MRA) (21 +/- 1 vs. 24 +/- 1 ms, P < 0.05). Darifenacin eliminated this difference (HRA: 37 +/- 2 vs. 39 +/- 2 ms, and MRA: 30 +/- 2 vs. 30 +/- 1, P > 0.4). RGS2(-/-) were more susceptible than WT mice to atrial tachycardia/fibrillation (AT/F) induction (11/22 vs. 1/25, respectively, P < 0.05). Muscarinic receptor expression did not differ between strains, whereas M2R expression was 70-fold higher than M3R (P < 0.01). These results suggest that RGS2 is an important cholinergic regulator in the atrium and that RGS2(-/-) mice have enhanced susceptibility to AT/F via enhanced M3 muscarinic receptor activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19966055     DOI: 10.1152/ajpheart.00779.2009

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  20 in total

1.  The Role of Inhibitory G Proteins and Regulators of G Protein Signaling in the in vivo Control of Heart Rate and Predisposition to Cardiac Arrhythmias.

Authors:  Richard Ang; Aaisha Opel; Andrew Tinker
Journal:  Front Physiol       Date:  2012-04-24       Impact factor: 4.566

Review 2.  Regulators of G-protein signaling in the heart and their potential as therapeutic targets.

Authors:  Peng Zhang; Ulrike Mende
Journal:  Circ Res       Date:  2011-07-22       Impact factor: 17.367

3.  Absence of the Regulator of G-protein Signaling, RGS4, Predisposes to Atrial Fibrillation and Is Associated with Abnormal Calcium Handling.

Authors:  Aaisha Opel; Muriel Nobles; David Montaigne; Malcolm Finlay; Naomi Anderson; Ross Breckenridge; Andrew Tinker
Journal:  J Biol Chem       Date:  2015-06-18       Impact factor: 5.157

4.  Cardiotonic steroids stabilize regulator of G protein signaling 2 protein levels.

Authors:  Benita Sjögren; Sergio Parra; Lauren J Heath; Kevin B Atkins; Zie-Jian Xie; Richard R Neubig
Journal:  Mol Pharmacol       Date:  2012-06-13       Impact factor: 4.436

5.  Role of Cholinergic Innervation and RGS2 in Atrial Arrhythmia.

Authors:  Douglas L Jones; Jari M Tuomi; Peter Chidiac
Journal:  Front Physiol       Date:  2012-06-29       Impact factor: 4.566

Review 6.  Functional role, mechanisms of regulation, and therapeutic potential of regulator of G protein signaling 2 in the heart.

Authors:  Peng Zhang; Ulrike Mende
Journal:  Trends Cardiovasc Med       Date:  2013-08-17       Impact factor: 6.677

7.  Scn2b Deletion in Mice Results in Ventricular and Atrial Arrhythmias.

Authors:  Yangyang Bao; B Cicero Willis; Chad R Frasier; Luis F Lopez-Santiago; Xianming Lin; Roberto Ramos-Mondragón; David S Auerbach; Chunling Chen; Zhenxun Wang; Justus Anumonwo; Héctor H Valdivia; Mario Delmar; José Jalife; Lori L Isom
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-12

Review 8.  Regulators of G protein signaling in cardiovascular function during pregnancy.

Authors:  Katherine J Perschbacher; Guorui Deng; Rory A Fisher; Katherine N Gibson-Corley; Mark K Santillan; Justin L Grobe
Journal:  Physiol Genomics       Date:  2018-04-27       Impact factor: 3.107

9.  Atrial tachyarrhythmia in Rgs5-null mice.

Authors:  Mu Qin; He Huang; Teng Wang; He Hu; Yu Liu; Yongwei Gu; Hong Cao; Hongliang Li; Congxin Huang
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

10.  Identification of new therapeutic targets by genome-wide analysis of gene expression in the ipsilateral cortex of aged rats after stroke.

Authors:  Ana-Maria Buga; Claus Jürgen Scholz; Senthil Kumar; James G Herndon; Dragos Alexandru; Gabriel Radu Cojocaru; Thomas Dandekar; Aurel Popa-Wagner
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.